Allard D - Search Results

1

Methylmalonic acid analysis using urine filter paper samples to screen for metabolic vitamin B₁₂ deficiency in older adults.

Boutin M, Presse N, Allard D, Martineau T, Gaudreau P, Auray-Blais C. Boutin M, et al. Among authors: allard d. Bioanalysis. 2022 May;14(9):615-626. doi: 10.4155/bio-2022-0007. Epub 2022 May 12. Bioanalysis. 2022. PMID: 35546317

2

[No title available]

[No authors listed] [No authors listed] PMID: 35746882

3

Vitamin B-12 Intake from Dairy but Not Meat Is Associated with Decreased Risk of Low Vitamin B-12 Status and Deficiency in Older Adults from Quebec, Canada.

Huang HH, Cohen AA, Gaudreau P, Auray-Blais C, Allard D, Boutin M, Reid I, Turcot V, Presse N. Huang HH, et al. Among authors: allard d. J Nutr. 2022 Nov;152(11):2483-2492. doi: 10.1093/jn/nxac143. Epub 2022 Jun 23. J Nutr. 2022. PMID: 36774114 Free PMC article.

4

CD73 Promotes Chronic Lymphocytic Leukemia.

Allard D, Chrobak P, Bareche Y, Allard B, Tessier P, Bergeron MA, Johnson NA, Stagg J. Allard D, et al. Among authors: allard b. Cancers (Basel). 2022 Jun 26;14(13):3130. doi: 10.3390/cancers14133130. Cancers (Basel). 2022. PMID: 35804900 Free PMC article.

5

The CD73 immune checkpoint promotes tumor cell metabolic fitness.

Allard D, Cousineau I, Ma EH, Allard B, Bareche Y, Fleury H, Stagg J. Allard D, et al. Elife. 2023 Jun 1;12:e84508. doi: 10.7554/eLife.84508. Elife. 2023. PMID: 37261423 Free PMC article.

6

Methods to Evaluate the Antitumor Activity of Immune Checkpoint Inhibitors in Preclinical Studies.

Allard B, Allard D, Stagg J. Allard B, et al. Among authors: allard d. Methods Mol Biol. 2016;1458:159-77. doi: 10.1007/978-1-4939-3801-8_12. Methods Mol Biol. 2016. PMID: 27581021

7

PolyI:C and CpG Synergize with Anti-ErbB2 mAb for Treatment of Breast Tumors Resistant to Immune Checkpoint Inhibitors.

Charlebois R, Allard B, Allard D, Buisseret L, Turcotte M, Pommey S, Chrobak P, Stagg J. Charlebois R, et al. Among authors: allard d, allard b. Cancer Res. 2017 Jan 15;77(2):312-319. doi: 10.1158/0008-5472.CAN-16-1873. Epub 2016 Nov 21. Cancer Res. 2017. PMID: 27872096

8

CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy.

Turcotte M, Allard D, Mittal D, Bareche Y, Buisseret L, José V, Pommey S, Delisle V, Loi S, Joensuu H, Kellokumpu-Lehtinen PL, Sotiriou C, Smyth MJ, Stagg J. Turcotte M, et al. Among authors: allard d. Cancer Res. 2017 Oct 15;77(20):5652-5663. doi: 10.1158/0008-5472.CAN-17-0707. Epub 2017 Aug 30. Cancer Res. 2017. PMID: 28855210

9

Targeting the CD73-adenosine axis in immuno-oncology.

Allard D, Chrobak P, Allard B, Messaoudi N, Stagg J. Allard D, et al. Among authors: allard b. Immunol Lett. 2019 Jan;205:31-39. doi: 10.1016/j.imlet.2018.05.001. Epub 2018 May 24. Immunol Lett. 2019. PMID: 29758241 Review.

10

Adenosine A2a receptor promotes lymphangiogenesis and lymph node metastasis.

Allard B, Cousineau I, Allard D, Buisseret L, Pommey S, Chrobak P, Stagg J. Allard B, et al. Among authors: allard d. Oncoimmunology. 2019 Apr 26;8(8):1601481. doi: 10.1080/2162402X.2019.1601481. eCollection 2019. Oncoimmunology. 2019. PMID: 31413909 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

251 results

Search Page